Protocol for the study and treatment of primary immune thrombocytopenia: ITP-2018
Por:
Monteagudo E, Astigarraga I, Cervera Á, Dasí MA, Sastre A, Berrueco R and Dapena JL
Publicada:
1 ago 2019
Ahead of Print:
6 jun 2019
Categoría:
Pediatrics, perinatology and child health
Resumen:
Primary immune thrombocytopenia, formerly known as immune thrombocytopenic purpura, is a disease for which the clinical and therapeutic management has always been controversial. The ITP working group of the Spanish Society of Paediatric Haematology and Oncology has updated its guidelines for diagnosis and treatment of primary immune thrombocytopenia in children, based on current guidelines, bibliographic review, clinical assays, and member consensus. The main objective is to reduce clinical variability in diagnostic and therapeutic procedures, in order to obtain best clinical results with minimal adverse events and good quality of life. (C) 2019 Asociacion Espanola de Pediatria. Published by Elsevier Espana, S.L.U.
Filiaciones:
Monteagudo E:
Servicio de Pediatría y sus Áreas Específicas, Hospital Infantil La Fe, Valencia, España
Astigarraga I:
Hospital de Cruces, Bilbao, España
Cervera Á:
Hospital de Móstoles, Madrid, España
Dasí MA:
Hospital Infantil La Fe, Valencia, España
Sastre A:
Hospital Infantil La Paz, Madrid, España
Berrueco R:
Hospital Sant Joan de Deu, Barcelona, España
Dapena JL:
Hospital Infantil Valle de Hebrón, Barcelona, España
gold
|